澳大利亚非肿瘤适应证近端股骨置换术的结局
基于澳大利亚骨科协会国家关节置换登记系统1999年9月1日至2023年12月31日的数据,共识别199例初次和161例首次翻修的PFR手术,初次PFR三年累积翻修率11.5%,1年死亡率15.7%;首次翻修PFR三年二次翻修率20.2%,1年死亡率20.0%。作者认为PFR用于非肿瘤适应证在增加,但翻修率和死亡率高,应尽可能考虑半髋置换以降低不稳定风险。
要点
- 初次PFR最常见适应证为股骨颈骨折(46.2%)和内固定失败(29.1%)。
- 初次PFR三年累积翻修率11.5%,翻修常见原因为不稳定(55.6%)和感染(33.3%)。
- 首次翻修PFR三年二次翻修率20.2%,1年死亡率20.0%。
核心结论
- PFR用于非肿瘤适应证在增加,虽为复杂近端股骨病变提供有吸引力的挽救选择,但翻修率和死亡率高,作者认为应尽可能考虑半髋置换以降低不稳定风险。
研究设计与样本
- 基于澳大利亚骨科协会国家关节置换登记系统的登记研究,纳入1999年9月1日至2023年12月31日非肿瘤适应证初次和首次翻修PFR手术,识别7种PFR假体。
主要发现
- 初次PFR共199例,包括58例半髋置换和141例全髋常规置换,最常见适应证为股骨颈骨折(46.2%)和内固定失败(29.1%)。
- 初次全髋常规PFR三年累积翻修率11.5%,翻修常见原因为不稳定(55.6%)和感染(33.3%),1年患者死亡率为15.7%。
- 首次翻修PFR共161例,最常见翻修适应证为骨折(47.8%),三年二次翻修率20.2%,二次翻修常见原因为感染(37.0%)和不稳定(37.0%),1年患者死亡率为20.0%。
临床怎么用
- 作者认为PFR是复杂近端股骨病变的挽救选择,但术者需注意其高翻修率和高死亡率;作者建议尽可能考虑半髋置换以降低不稳定风险。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Proximal femoral replacement (PFR) is commonly used to reconstruct the proximal femur following oncologic resection. A PFR may also be used for nononcologic indications; however, there is limited literature on outcomes following these procedures. The aim of this study was to investigate usage, implant survivorship, and patient mortality following primary and first revision PFR in Australia. METHODS: Data from the Australian Orthopaedic Association National Joint Replacement Registry were obtained for primary and first revision PFR procedures performed for nononcologic indications from September 1, 1999, to December 31, 2023. There were seven PFR prostheses identified. Kaplan-Meier estimates of implant survival were used to determine cumulative percent revision (CPR), and reasons for revision were examined. A 1-year patient mortality was determined. RESULTS: There were 199 primary PFR procedures identified, including 58 hemiarthroplasties and 141 total conventional procedures. The most common indications were fractured neck of femur (46.2%) and failed internal fixation (29.1%). At three years, the cumulative percent revision was 11.5% for total conventional PFR. Common reasons for revision included instability (55.6%) and infection (33.3%). The 1-year patient mortality was 15.7%. There were 161 first revision PFR procedures identified. The most common indication for revision was fracture (47.8%). At three years, the cumulative percent of second revision was 20.2%. Common reasons for the second revision included infection (37.0%) and instability (37.0%). The 1-year patient mortality was 20.0%. CONCLUSIONS: The use of PFR for nononcologic indications is increasing. Although PFR offers an attractive salvage option for complex proximal femoral pathology, surgeons need to be mindful of the high revision and mortality rates associated with this procedure. Hemiarthroplasty should be considered where possible to reduce the risk of instability. LEVEL OF EVIDENCE: III.
引用
- Aebischer AS, Lang-Lemckert J, Du P, et al. Outcomes of Proximal Femoral Replacement for Nononcologic Indications in Australia. J Arthroplasty. 2025. PMID: 40505749. doi:10.1016/j.arth.2025.06.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。